Benchling as Lab System of Record

Benchling is trying to become the system of record for how a biotech lab turns ideas into physical samples and results. The advantage of bundling notebook, registry, inventory, and workflow tools is that one experiment can carry its full trail, from the scientist's writeup, to the exact plasmid or cell line used, to where that sample sits in a freezer, to the next task assigned to another team. That makes handoffs easier and migration harder once a lab is fully set up.1 2 3 4 5 6

• Benchling's products are linked at the data model level, not just placed side by side. Registry records can be created from notebook work, moved into inventory containers, and pulled into workflows, while workflow templates can include registration and inventory tables. That is what makes traceability concrete across experiments.2 3 4 5
• Legacy competitors often grew from narrower starting points. Thermo Fisher's SampleManager centers on LIMS, SDMS, LES, and ELN for compliance heavy lab operations, while Dotmatics emphasizes connecting ELN, LIMS, and other systems and making experimental data searchable and AI ready. Benchling competes by replacing more of the daily scientist workflow inside one cloud system.7 8 9 10
• This integrated approach matters economically because Benchling already serves about 1,200 customers and was estimated at $210M ARR in mid 2024, with rising penetration into large biopharma accounts. Once a company has standardized schemas, sample IDs, permissions, and workflows in one system, ripping it out means retraining scientists and remapping years of experiment history.1 6

The next phase is moving from documentation into orchestration. As more labs connect instruments, automation, and analytics into the same system, the winning vendor will be the one that not only stores experiment history, but also routes the next step, governs the sample record, and becomes the default operating layer for R&D.5 10 11